MyHealthChecked PLC (MHC.L)
GBp 14.0
(0.0%)
GBp 14.0
(0.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 30 Thousand GBP | -113.53% |
| 2022 | 1.74 Million GBP | -61.02% |
| 2021 | 2.16 Million GBP | 193.48% |
| 2020 | -3.6 Million GBP | -27.19% |
| 2019 | -2.2 Million GBP | 16.93% |
| 2018 | -2.64 Million GBP | -18.44% |
| 2017 | -2.23 Million GBP | -129.51% |
| 2016 | -2.45 Million GBP | 16.63% |
| 2015 | -1.17 Million GBP | -48.92% |
| 2014 | -486.46 Thousand GBP | -455.64% |
| 2013 | -625.22 Thousand GBP | 73.42% |
| 2012 | -541.46 Thousand GBP | -18.41% |
| 2011 | -448.92 Thousand GBP | -27.6% |
| 2010 | -393.79 Thousand GBP | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | -612 Thousand GBP | -785.71% |
| 2024 Q2 | -612 Thousand GBP | 0.0% |
| 2023 Q3 | 100.5 Thousand GBP | 131.9% |
| 2023 Q2 | -315 Thousand GBP | -100.0% |
| 2023 Q1 | -157.5 Thousand GBP | -108.64% |
| 2023 Q4 | 89.25 Thousand GBP | -11.19% |
| 2023 FY | - GBP | -113.53% |
| 2022 Q4 | 1.82 Million GBP | 115.06% |
| 2022 Q3 | 847.66 Thousand GBP | 368.32% |
| 2022 FY | - GBP | -61.02% |
| 2022 Q1 | 167 Thousand GBP | -93.07% |
| 2022 Q2 | 181 Thousand GBP | 8.38% |
| 2021 Q1 | -103 Thousand GBP | 95.63% |
| 2021 Q4 | 2.4 Million GBP | 74.39% |
| 2021 Q3 | 1.38 Million GBP | 769.79% |
| 2021 FY | - GBP | 193.48% |
| 2021 Q2 | -206.26 Thousand GBP | -100.25% |
| 2020 Q1 | -622.95 Thousand GBP | 37.39% |
| 2020 FY | - GBP | -27.19% |
| 2020 Q3 | -779.21 Thousand GBP | 37.46% |
| 2020 Q4 | -2.35 Million GBP | -202.22% |
| 2020 Q2 | -1.24 Million GBP | -100.0% |
| 2019 Q3 | -538.43 Thousand GBP | 55.36% |
| 2019 FY | - GBP | 16.93% |
| 2019 Q4 | -994.91 Thousand GBP | -84.78% |
| 2019 Q2 | -1.2 Million GBP | -100.0% |
| 2019 Q1 | -603.04 Thousand GBP | 4.63% |
| 2018 Q2 | -670.59 Thousand GBP | 0.0% |
| 2018 Q1 | -670.59 Thousand GBP | -9.51% |
| 2018 Q3 | -617.78 Thousand GBP | 7.88% |
| 2018 Q4 | -632.3 Thousand GBP | -2.35% |
| 2018 FY | - GBP | -18.44% |
| 2017 Q1 | -535.86 Thousand GBP | 0.0% |
| 2017 FY | - GBP | -129.51% |
| 2017 Q2 | -535.86 Thousand GBP | 0.0% |
| 2017 Q3 | -612.36 Thousand GBP | -14.28% |
| 2017 Q4 | -612.36 Thousand GBP | 0.0% |
| 2016 FY | - GBP | 16.63% |
| 2015 FY | - GBP | -48.92% |
| 2014 FY | - GBP | -455.64% |
| 2013 FY | - GBP | 73.42% |
| 2012 FY | - GBP | -18.41% |
| 2011 FY | - GBP | -27.6% |
| 2010 FY | - GBP | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|